PT84457A - Verwendung aminosubstituierter benzoesaeuren als heilmittel gegn diarrhoe und arzneimittel auf basis dieser verbindungen - Google Patents

Verwendung aminosubstituierter benzoesaeuren als heilmittel gegn diarrhoe und arzneimittel auf basis dieser verbindungen

Info

Publication number
PT84457A
PT84457A PT84457A PT8445787A PT84457A PT 84457 A PT84457 A PT 84457A PT 84457 A PT84457 A PT 84457A PT 8445787 A PT8445787 A PT 8445787A PT 84457 A PT84457 A PT 84457A
Authority
PT
Portugal
Prior art keywords
benzoesaeures
diarrhoe
amino
substituted
compounds
Prior art date
Application number
PT84457A
Other languages
German (de)
English (en)
Other versions
PT84457B (pt
Inventor
Heinrich Christian Englert
Max Hropot
Hans-Jochen Lang
Rainer Greger
Original Assignee
Hoechst Ag
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag, Max Planck Gesellschaft filed Critical Hoechst Ag
Publication of PT84457A publication Critical patent/PT84457A/pt
Publication of PT84457B publication Critical patent/PT84457B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12Antidiarrhoeals
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT84457A 1986-03-15 1987-03-12 Processo para a preparacao de medicamentos contra a diarreia contendo acidos benzoicos amino-substituidos como ingredientes activos PT84457B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863608726 DE3608726A1 (de) 1986-03-15 1986-03-15 Verwendung aminosubstituierter benzoesaeuren als heilmittel gegen diarrhoe und arzneimittel auf basis dieser verbindungen

Publications (2)

Publication Number Publication Date
PT84457A true PT84457A (de) 1987-04-01
PT84457B PT84457B (pt) 1989-10-04

Family

ID=6296458

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84457A PT84457B (pt) 1986-03-15 1987-03-12 Processo para a preparacao de medicamentos contra a diarreia contendo acidos benzoicos amino-substituidos como ingredientes activos

Country Status (6)

Country Link
US (1) US4921875A (pt)
EP (1) EP0242559A3 (pt)
JP (1) JPS62221659A (pt)
DE (1) DE3608726A1 (pt)
DK (1) DK131187A (pt)
PT (1) PT84457B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9300658D0 (sv) * 1993-02-26 1993-02-26 Astra Ab New compounds
WO2000041505A2 (en) * 1999-01-13 2000-07-20 Warner-Lambert Company Anthranilic acid derivatives
DE60127098T2 (de) * 2000-01-31 2007-11-29 Genaera Corp. Inhibitoren der mucin-synthese
US7345051B2 (en) 2000-01-31 2008-03-18 Genaera Corporation Mucin synthesis inhibitors
JP2005515253A (ja) 2002-01-23 2005-05-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー N−(4−置換フェニル)−アントラニル酸ヒドロキサメートエステル
DOP2003000556A (es) 2002-01-23 2003-10-31 Warner Lambert Co Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico.
AU2004249775A1 (en) * 2003-06-19 2004-12-29 Genaera Corporation Mucin synthesis inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL45357A (en) * 1974-07-26 1978-04-30 Yeda Res & Dev Pharmaceutical compositions comprising aromatic amino acids as inhibitors of prostaglandin action
US4029815A (en) * 1975-04-30 1977-06-14 Schering Corporation Anti-diarrheal anthranilic acids

Also Published As

Publication number Publication date
DK131187A (da) 1987-09-16
DE3608726A1 (de) 1987-09-17
DK131187D0 (da) 1987-03-13
PT84457B (pt) 1989-10-04
EP0242559A3 (de) 1990-05-23
JPS62221659A (ja) 1987-09-29
US4921875A (en) 1990-05-01
EP0242559A2 (de) 1987-10-28

Similar Documents

Publication Publication Date Title
DE3751845D1 (de) Stabilisiertes Arzneimittel und dessen Herstellung
IT8021789A0 (it) Regolatore impiantabile perl'infusione di sostanze medicinali.
DE3770085D1 (de) Cyclodextrinclathrate von carbacyclinderivaten und ihre verwendung als arzneimittel.
FI94028B (fi) Laite nenäsairauksien diagnoosia ja hoitoa varten
DK376589A (da) Engangssproejte
DK187590A (da) Injektionssproejte
ATE65915T1 (de) Stabilisierte arzneimittelzubereitungen.
EP0569862A3 (en) Self-adhesive medical sheet and medical preparation.
NO893077L (no) Fludium for behandling av en broenn.
JPS567719A (en) Drug for prevention and remedy of infection
PH23996A (en) New substituted thiazoles and oxazoles and medicaments containing these compounds
FI884048A7 (fi) Foerfarande foer bestaemning av halten av en gaskomponent i en patients andningsluft.
PT84457A (de) Verwendung aminosubstituierter benzoesaeuren als heilmittel gegn diarrhoe und arzneimittel auf basis dieser verbindungen
NO171857C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater
NO873923D0 (no) Fremgangsmaate for fremstilling av et medisinsk hudpreparat
DK95489D0 (da) Anvendelse af quinolizin- og quinolizinonderivater til fremstilling af et laegemiddel
ATA901688A (de) Cyclodextrinclathrate von 5-cyanoprostacyclinderivaten und ihre verwendung als arzneimittel
DE69026077D1 (de) Medizinische verwendung von m-csf
DE3786562D1 (de) 2,6-dideoxy-2-fluoro-l-talopyranose, derivate davon und herstellung dieser verbindungen.
KR900701341A (ko) 일회용 주사기
ATA316887A (de) Herstellung und verwendung neuer azolderivate, und sie enthaltende pharmazeutische praeparate
ATA254988A (de) Einwegspritze
DK38986A (da) Medicinsk inhalationsapparat
NO164253C (no) Behandling av stoev.
DK162479C (da) Infusionskanyle

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19920930